Form 4: Johnson & Johnson Director McClellan Acquires Deferred Share Units

Director Mark B. McClellan acquired 1,316 deferred share units (DSUs) of Johnson & Johnson on April 24, 2025, under the company's Amended and Restated Deferred Fee Plan for Directors.

Summary

• On April 24, 2025, Mark B. McClellan, a director of Johnson & Johnson, acquired 1,316 Deferred Share Units (DSUs) under the Issuer's Amended and Restated Deferred Fee Plan for Directors.
• These DSUs will be settled in cash upon the termination of McClellan's directorship, with each DSU representing the fair market value of one share of Johnson & Johnson common stock on the settlement date.
• Following the transaction, McClellan beneficially owns 19,755.232 shares, which includes dividend equivalent rights accrued on the DSUs.
• The transaction was reported on a Form 4 filing with the SEC on April 28, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of DSUs by a director is generally seen as a positive sign, indicating confidence in the company's future performance. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of DSUs by a director signals confidence in the company's future performance.

Future Outlook

The DSUs will be settled in cash upon termination of the Reporting Person's directorship, with each DSU representing the fair market value of one share of Common Stock on the settlement date.

Industry Context

This filing is a routine disclosure of a director's compensation in the form of deferred share units, a common practice among publicly traded companies to align the interests of directors with those of shareholders.

Comparison to Industry Standards

• Deferred share unit grants are a common form of executive compensation in large, publicly traded companies like Johnson & Johnson.
• Companies such as Pfizer (PFE) and Merck (MRK) also utilize similar deferred compensation plans for their directors and executives.
• The specific number of units granted and the terms of the plan are generally in line with industry practices for companies of similar size and market capitalization.

Stakeholder Impact

• The acquisition of DSUs by a director aligns their interests with those of shareholders, potentially encouraging decisions that benefit the company's long-term value.

Key Dates

Keywords

Deferred Share Units, Director, Form 4, Johnson & Johnson, JNJ, Beneficial Ownership, SEC Filing